DavidMRindMD
Internal Medicine • Boston, MAAssistant Clinical Professor of Medicine, Beth Israel Deaconess Medical Center
Are you Dr. Rind?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-2700Fax+1 617-667-6405
Summary
- Dr. David Rind, MD is a board certified internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is an Assistant Clinical Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
University of Rochester School of Medicine and DentistryClass of 1986
Certifications & Licensure
MA State Medical License 1987 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA.Jyotirmoy Sarker, Jeffrey A Tice, David M Rind, Surrey M Walton
Applied Health Economics and Health Policy. 2024-12-02 - 2 citationsA network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.Abigail C Wright, Avery McKenna, Jeffrey A Tice, David M Rind, Foluso Agboola
Schizophrenia Research. 2024-12-01 - Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch.Marina Richardson, Abigail C Wright, Jeffrey A Tice, David M Rind, Matt Seidner
Value in Health. 2024-11-01
Press Mentions
How a Leftist Activist Group Helped Torpedo a Psychedelic TherapyFebruary 4th, 2025- FDA Approves New Type of Nonopioid Painkiller for Acute PainJanuary 30th, 2025
- FDA Approves New Kind of Drug for SchizophreniaSeptember 28th, 2024
- Join now to see all
